UPC CoA 744/2025
Aug 13, 2025·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase Closed (Withdrawn)ActionAppealCategoryMain appeal
- Parties
- Division
- Court of Appeal
- Judges
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- First decided
- Feb 18, 2026
- EPO Opposition
- Samsung Bioepis NL B.V.Withdrawn2024-05-02
- Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
- Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Rian Kalden | Locked |
At the UPC: Samsung Group (57 cases)·AstraZeneca Group (13 cases)
This dispute contains 6 other proceedings
UPC CFI 674/2025·UPC CFI 51/2025·UPC CFI 40/2025·UPC APP 43786/2024·UPC CoA 402/2024 and 1 more
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: Court of Appeal·2025
- 2026-02-18Application RoP 265Public
Summary: The Court of Appeal permitted Samsung Bioepis NL B.V.'s withdrawal of two applications for leave to appeal cost decisions (UPC_CoA_744/2025 and UPC_CoA_750/2025) in proceedings relating to provisional measures dismissed for lack of urgency before the Hamburg Local Division. Alexion consented to the withdrawal and waived any costs claim. The proceedings were declared closed with no costs order.
Show the legal issues (2)
- Withdrawal of application for leave to appeal under R. 265.1 RoP
- Costs in provisional measures proceedings
| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-02-19 | Not public |
| Decision | 2026-02-18 | Not public |
| Decision | 2026-02-18 | Public |
| Receipt | 2026-02-04 | Not public |
| Cover sheet | 2026-02-04 | Not public |
| Other document Defendant | 2026-02-04 | Not public |
| Receipt | 2026-01-31 | Not public |
| Cover sheet | 2026-01-31 | Not public |
| Application document Claimant | 2026-01-30 | Not public |
| Order | 2026-01-07 | Not public |